How has the exit activity for health technology developed in the first half of 2019? This blog post explores health technology exit metrics through Q2 2019 and compares them to previous years. The graph below shows the number of health technology exits by year, stacked by quarters.
As the graphic demonstrates, health technology has seen a total of 37 exit events through Q2 of this year. This represents 56% of the total exits in 2018, and 88% of the exits through Q2 in 2018. Some of the exit events in Q2 2019 include Exonics Therapeutics’ acquisition by Vertex Pharmaceuticals, PatientsLikeMe’s acquisition by the UnitedHealth Group, and Beyond Meat’s IPO.
A straight-line projection of the completed exit activity this year would come out to 74 exit events, which exceeds the total exits in 2018 by 12%. On the other hand, a weighted quarterly average projection of 2019 exit activity would come out to 58 exit events, which falls short of the total exits in 2018 by 12%. Therefore, based on the mid-year data, health technology exit activity in 2019 is projected to be relatively equal to the exit activity in 2018.